Is Johnson & Johnson (JNJ) a Laggard in the Healthcare Sector?

A rating of 28 puts Johnson & Johnson (JNJ) near the top of the Healthcare sector according to InvestorsObserver. Johnson & Johnson's score of 28 means that it ranks higher than 28% of stocks in the sector. In addition, its overall score of 48 ranks it higher than 48% of all stocks.

JNJ has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on JNJ!

See Full JNJ Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Johnson & Johnson Stock Today?

Johnson & Johnson (JNJ) stock has gained 0.6% while the S&P 500 is down -0.28% as of 12:17 PM on Friday, Mar 24. JNJ has risen $0.91 from the previous closing price of $151.05 on volume of 1,933,130 shares. Over the past year the S&P 500 has fallen -12.89% while JNJ is down -13.28%. JNJ earned $6.73 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 22.56. Click Here to get the full Stock Report for Johnson & Johnson stock.